These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 34604232)
1. Metabolites Profiling of Melanoma Interstitial Fluids Reveals Uridine Diphosphate as Potent Immune Modulator Capable of Limiting Tumor Growth. Vecchio E; Caiazza C; Mimmi S; Avagliano A; Iaccino E; Brusco T; Nisticò N; Maisano D; Aloisio A; Quinto I; Renna M; Divisato G; Romano S; Tufano M; D'Agostino M; Vigliar E; Iaccarino A; Mignogna C; Andreozzi F; Mannino GC; Spiga R; Stornaiuolo M; Arcucci A; Mallardo M; Fiume G Front Cell Dev Biol; 2021; 9():730726. PubMed ID: 34604232 [TBL] [Abstract][Full Text] [Related]
2. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
3. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration. Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142 [TBL] [Abstract][Full Text] [Related]
4. Oncolytic adenovirus decreases the proportion of TIM-3 Liikanen I; Basnet S; Quixabeira DCA; Taipale K; Hemminki O; Oksanen M; Kankainen M; Juhila J; Kanerva A; Joensuu T; Tähtinen S; Hemminki A J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35193929 [TBL] [Abstract][Full Text] [Related]
5. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3. Quatromoni JG; Morris LF; Donahue TR; Wang Y; McBride W; Chatila T; Economou JS J Hematol Oncol; 2011 Nov; 4():48. PubMed ID: 22112546 [TBL] [Abstract][Full Text] [Related]
6. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer. Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721 [TBL] [Abstract][Full Text] [Related]
7. Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade. Santinon F; Ezzahra BF; Bachais M; Sarabia Pacis A; Rudd CE Sci Rep; 2022 Nov; 12(1):18509. PubMed ID: 36323740 [TBL] [Abstract][Full Text] [Related]
8. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells). Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244 [TBL] [Abstract][Full Text] [Related]
9. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma. Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987 [TBL] [Abstract][Full Text] [Related]
10. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1. Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers of tumor-reactive CD4 Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36581331 [TBL] [Abstract][Full Text] [Related]
12. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
13. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization. Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559 [TBL] [Abstract][Full Text] [Related]
14. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
15. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer]. Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667 [No Abstract] [Full Text] [Related]
16. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129 [TBL] [Abstract][Full Text] [Related]
17. STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity. Rossi M; Carboni S; Di Berardino-Besson W; Riva E; Santiago-Raber ML; Belnoue E; Derouazi M Front Immunol; 2021; 12():695056. PubMed ID: 34276686 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557 [TBL] [Abstract][Full Text] [Related]
19. Recovery Profiles of T-Cell Subsets Following Low-Dose Total Body Irradiation and Improvement With Cinnamon. Zheng X; Guo Y; Wang L; Zhang H; Wang S; Wang L; An L; Zhou X; Li X; Yao C Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1118-26. PubMed ID: 26475064 [TBL] [Abstract][Full Text] [Related]
20. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells. Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]